No description available.

Peripheral nerve injuries are often associated with loss of nerve tissue and require autologous nerve grafts to provide a physical substrate for axonal growth. This thesis investigates the use of fibrin as both a tubular conduit to guide nerve regeneration and also as a matrix material to suspend various regenerative cell types within/on poly-3-hydroxybutyrate (PHB) nerve conduits. Adipose derived stem cells (ASC) are found in abundant quantities. In this thesis the ability of rat ASC to differentiate into Schwann cells was determined and a preliminary study of the neurotrophic potential of human ASC was also investigated. Rat sciatic nerve axotomy was performed proximally in the thigh to create a 10-mm gap between the nerve stumps and the gap was bridged using the various conduits.  At early time points the nerve grafts were harvested and investigated for axonal and Schwann cell markers.  After 16 weeks the regenerative response from sensory and motor neurons was also evaluated following retrograde labelling with Fast Blue fluorescent tracer. Stem cells were treated with a mixture of glial growth factors and after 2 weeks in vitro the expression of Schwann cell markers was analysed by immunocytochemistry and Western blotting.  ASC were cocultured with the NG108-15 neuronal cell line to determine their ability to promote neurite outgrowth.  Human ASC were isolated from the deep and superficial layers of abdominal fat tissue obtained during abdominoplasty procedures.  RT-PCR was used to investigate the expression of neurotrophic factors. Immunohistochemistry showed a superior nerve regeneration distance in the fibrin conduit compared with PHB. The fibrin conduit promoted regeneration of 60% of sensory neurones and 52% of motor neurones when compared with an autograft group at 16 weeks. The total number of myelinated axons in the distal nerve stump in the fibrin-conduit group reached 86% of the graft and the weight of gastrocnemius and soleus muscles recovered to 82% and 89% of the controls, respectively. In vitro studies showed that rat ASC could be differentiated to a Schwann cell phenotype. These treated cells enhanced both the number of NG108-15 cells expressing neurites and neurite length. In the same coculture model system, human superficial fat layer ASC induced significantly enhanced neurite outgrowth when compared with the deep layer fat cells. RT-PCR analysis showed ASC isolated from both layers expressed neurotrophic factors. These results indicate that a tubular fibrin conduit can be used to promote neuronal regeneration following peripheral nerve injury. There was also a beneficial effect of using a fibrin matrix to seed cells within/on PHB conduits which should ultimately lead to improved functional recovery following nerve injury.  There might also be an advantage to use a simple strip of PHB rather than a conventional tube-like structure implying that single fascicle nerve grafting could be advantageous for nerve repair.  The results of in vitro experiments indicate adipose tissue contains a pool of regenerative stem cells which can be differentiated to a Schwann cell phenotype and given that human ASC express a range of neurotrophic factors they are likely to be of clinical benefit for treatment of peripheral nerve injuries.

京都大学 / 新制・課程博士 / 博士(医学) / 甲第24481号 / 医博第4923号 / 新制||医||1063(附属図書館) / 京都大学大学院医学研究科医学専攻 / (主査)教授 高橋 淳, 教授 髙橋 良輔, 教授 井上 治久 / 学位規則第4条第1項該当 / Doctor of Medical Science / Kyoto University / DFAM

There are different methods used in the surgical treatment of peripheral nerve injury. In this respect, end-to-end surgical reconnection of the damaged nerve ends or autologous nerve grafts are applied as soon as possible after the injury. When autologous tissue transplant is considered, there are some medical devices available generally for relatively short nerve defects. As a solution for this problem, different tissue engineered nerve conduits have been developed. In the current study, a pHEMA hydrogel membranes were designed to mimic the tubular conduits and they were loaded with 1-6% (w/w) multiwalled carbon nanotubes (mwCNTs) to obtain electrical conductivity. The most important reason for the use of CNTs in peripheral nerve injury is their electrical conductivity. Within the context of the study, the degree of swelling, contact angles, electrical conductivity and mechanical properties of the membranes were analyzed. As the amount of mwCNTs were increased, the contact angles, indicating higher hydrophobicity and the electrical conductivity increased. The tensile test of the mwCNT-pHEMA composite membranes showed that the membranes have viscoelastic structure similar to the structure of the soft tissues. The structure of the mwCNT containing pHEMA composite membranes were analyzed with different microscopical techniques such as SEM, CSLM and microCT. MwCNTs on the hydrogels were morphologically similar to the original. SEM micrographs also showed that the mwCNTs were grouped in clumps on hydrogel surfaces. No mwCNT leaching was observed because the mwCNTs were embedded in the hydrogel, therefore, no cytotoxic effect was observed. The pHEMA hydrogels were porous which is suitable for transportation of materials, electrolytes and gas needed for cell nutrition and growth. In the in vitro studies, SHSY5Y neuroblastoma cells were seeded on the membranes to determine the sustainability and effects of the membranes on the cell growth. Electrical potential of 1 and 2 V were used to stimulate the cells. Microscopical examination with SEM and CSLM, and MTT viability assay were used. The SHSY5Y neuroblastoma cells were attached and proliferated on both the composite and the hydrogel membranes. The cells on pHEMA membranes without mwCNTs, however, were not able to survive after application of electrical potential. As a conclusion, use of composite membranes in the treatment of peripheral nerve injury as a nerve conduit is appropriate. Electrical stimulation, however, did not induce the cells to align in contrast to the expected results, indicating potential and current application regime needs to be optimized to obtain the desired results.

No description available.

Peripheral nerve trauma is a common cause of considerable functional morbidity, and healthcare expenditure. Particularly in the ~15% of injuries unsuitable for primary repair, standard clinical management results in inadequate sensory restitution in the majority of cases, despite the rigorous application of complex microsurgical techniques. This can largely be explained by the failure of surgical management to adequately address the neurobiological hurdles to optimal regeneration. Most significant of these is the extensive sensory neuronal death that follows injury, and which is accompanied by a reduction in the regenerative potential of axotomised neurons, and in the supportive capacity of the Schwann cell population if nerve repair is delayed. The present study aimed to accurately delineate the timecourse of neuronal death, in order to identify a therapeutic window during which clinically applicable neuroprotective strategies might be adopted. It then proceeded to investigate means to increase the regenerative capacity of chronically axotomised neurons, and to augment the Schwann cells’ ability to promote that regenerative effort. Unilateral sciatic nerve transection in the rat was the model used, initially assessing neuronal death within the L4&5 dorsal root ganglia by a combination of morphology, TdT uptake nick-end labelling (TUNEL), and statistically unbiased estimation of neuronal loss using the stereological optical disector technique. Having identified 2 weeks, and 2 months post-axotomy as the most biologically relevant timepoints to study, the effect upon neuronal death of systemic treatment with acetyl-L-carnitine (ALCAR 10, or 50mg/kg/day) or N-acetyl-cysteine (NAC 30, or 150mg/kg/day) was determined. A model of secondary nerve repair was then adopted; either 2 or 4 months after unilateral sciatic nerve division, 1cm gap repairs were performed using either reversed isografts, or poly-3-hydroxybutyrate (PHB) conduits containing an alginate-fibronectin hydrogel. Six weeks later nerve regeneration and the Schwann cell population were quantified by digital image analysis of frozen section immunohistochemistry. Sensory neuronal death begins within 24 hours of injury, but takes 1 week to translate into significant neuronal loss. The rate of neuronal death peaks 2 weeks after injury, and neuronal loss is essentially complete by 2 months post-axotomy. Nerve repair is incompletely neuroprotective, but the earlier it is performed the greater the benefit. Two clinically safe pharmaceutical agents, ALCAR & NAC, were found to virtually eliminate sensory neuronal death after peripheral nerve transection. ALCAR also enhanced nerve regeneration independently of its neuroprotective role. Plain PHB conduits were found to be technically simple to use, and supported some regeneration, but were not adequate in themselves. Leukaemia inhibitory factor enhanced nerve regeneration, though cultured autologous Schwann cells (SC’s) were somewhat more effective. Both were relatively more efficacious after a 4 month delay in nerve repair. The most profuse regeneration was found with recombinant glial growth factor (rhGGF-2) in repairs performed 2 months after axotomy, with results that were arguably better than were obtained with nerve grafts. A similar conclusion can be drawn from the result found using both rhGGF-2 and SC’s in PHB conduits 4 months after axotomy. In summary, these findings reinforce the significance of sensory neuronal death in peripheral nerve trauma, and the possibility of its` limitation by early nerve repair. Two agents for the adjuvant therapy of such injuries were identified, that can virtually eliminate neuronal death, and enhance regeneration. Elements in the creation of a bioartificial nerve conduit to replace, or surpass autologous nerve graft for secondary nerve repair are presented.

Introduction : Les conduits nerveux synthétiques représentent une alternative chirurgicale aux autogreffes dans la réparation des traumatismes aux nerfs périphériques. Afin d’améliorer la régénération nerveuse périphérique, plusieurs biomatériels, tels que la multicouche polyélectrolyte de soie (MPE), et modèles ont été étudiés. Dans le cadre de ma maitrise, nos objectifs de recherche sont d’établir si la MPE de soie permet d’améliorer la régénération nerveuse périphérique in vivo et si notre nouveau modèle de conduit (« jelly roll ») peut mener à une meilleure régénération du nerf sciatique chez le rat que le modèle de conduit creux. Méthodes : Dans cette étude, une technique chirurgicale in vivo de lacération et de réparation du nerf sciatique chez le rat fut utilisé. Cinq conditions expérimentales de conduits (autogreffe, conduit creux avec et sans MPE de soie et « jelly roll » avec et sans MPE de soie) furent implantées (n= 2 rats par condition). Après 4 semaines, les conduits furent récupérés et marqués par immunohistochimie avec le neurofilament et la protéine basique de la myéline (MBP). La performance de chaque conduit fut évaluée par sa capacité à supporter l’excroissance axonale à travers le long du conduit et à travers la largeur de ce dernier à divers endroits. Résultats : Chaque condition expérimentale a supporté une régénération axonale avec différents degrés de succès. Globalement, l’autogreffe a supporté une plus longue croissance de fibres. De plus, la surface de fibres obtenue était plus large que les autres conditions. Les conduits avec la MPE de soie ont eu une performance similaire à leurs homologues sans soie. De plus, le modèle de conduit creux a mené à une meilleure régénération axonale que le modèle du « jelly roll ». Conclusion : L’autogreffe demeure le meilleur conduit pour supporter la régénération nerveuse périphérique. Les conduits avec la MPE de soie peuvent supporter une régénération nerveuse similaire aux conduits sans soie tandis que le modèle de « jelly roll » a généré des performances inférieures au modèle de conduit creux. / Background: Synthetic nerve conduits constitute alternative surgical options to autografts in the repair of peripheral nerve injuries. Silk polyelectrolyte multilayer (PEM) as a biomaterial and novel conduit designs have been proposed to improve peripheral nerve regeneration. In my master’s project, my objective is to assess whether silk PEM can improve peripheral nerve regeneration in vivo and to assess whether our novel conduit design (“jelly roll”) can better support rat sciatic nerve regeneration than a hollow conduit design. Methods: In this study, an in vivo rat model of sciatic nerve laceration and repair was used. Five experimental conduit conditions (autograft, hollow conduit with and without silk PEM, and jelly roll with and without silk PEM) were implanted (n=2 rats per condition). After 4 weeks, the conduits were harvested and immuno-stained for neurofilament and myelin basic protein (MBP). Conduit performance was assessed by its ability to support axonal outgrowth throughout the conduit’s length and at various locations along its width. Results: Each condition supported axonal regeneration at varying levels of success. Overall, the autograft group outperformed all other groups by supporting the longest and widest occupying regenerating fibers. Conduits with silk PEM performed similarly to conduits without silk PEM. In addition, the hollow conduit design demonstrated better regenerative outcomes than the jelly roll design. Conclusion: The autograft remains the superior conduit to support peripheral nerve regeneration. Conduits with silk PEM support nerve regeneration in the same capacity as non silk-coated conduits while the jelly roll design underperformed in comparison to the hollow conduit design.